1. Home
  2. TENX vs KLXE Comparison

TENX vs KLXE Comparison

Compare TENX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • KLXE
  • Stock Information
  • Founded
  • TENX 1967
  • KLXE 2018
  • Country
  • TENX United States
  • KLXE United States
  • Employees
  • TENX N/A
  • KLXE N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • TENX Health Care
  • KLXE Energy
  • Exchange
  • TENX Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • TENX 31.9M
  • KLXE 35.8M
  • IPO Year
  • TENX N/A
  • KLXE N/A
  • Fundamental
  • Price
  • TENX $7.70
  • KLXE $1.65
  • Analyst Decision
  • TENX Strong Buy
  • KLXE
  • Analyst Count
  • TENX 2
  • KLXE 0
  • Target Price
  • TENX $17.00
  • KLXE N/A
  • AVG Volume (30 Days)
  • TENX 59.3K
  • KLXE 122.5K
  • Earning Date
  • TENX 11-12-2025
  • KLXE 11-05-2025
  • Dividend Yield
  • TENX N/A
  • KLXE N/A
  • EPS Growth
  • TENX N/A
  • KLXE N/A
  • EPS
  • TENX N/A
  • KLXE N/A
  • Revenue
  • TENX N/A
  • KLXE $645,200,000.00
  • Revenue This Year
  • TENX N/A
  • KLXE N/A
  • Revenue Next Year
  • TENX N/A
  • KLXE N/A
  • P/E Ratio
  • TENX N/A
  • KLXE N/A
  • Revenue Growth
  • TENX N/A
  • KLXE N/A
  • 52 Week Low
  • TENX $4.63
  • KLXE $1.46
  • 52 Week High
  • TENX $8.24
  • KLXE $7.40
  • Technical
  • Relative Strength Index (RSI)
  • TENX 60.46
  • KLXE 41.01
  • Support Level
  • TENX $7.30
  • KLXE $1.59
  • Resistance Level
  • TENX $8.05
  • KLXE $1.75
  • Average True Range (ATR)
  • TENX 0.43
  • KLXE 0.12
  • MACD
  • TENX 0.05
  • KLXE -0.01
  • Stochastic Oscillator
  • TENX 79.87
  • KLXE 24.70

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: